These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9773260)

  • 1. Two-year treatment with oral contraceptives in hyperprolactinemic patients.
    Testa G; Vegetti W; Motta T; Alagna F; Bianchedi D; Carlucci C; Bianchi M; Parazzini F; Crosignani PG
    Contraception; 1998 Aug; 58(2):69-73. PubMed ID: 9773260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of physiological estrogen plus progestin replacement therapy and with oral contraceptive therapy in women with pathological hyperprolactinemia.
    Corenblum B; Donovan L
    Fertil Steril; 1993 Mar; 59(3):671-3. PubMed ID: 8458475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
    Ruchhoft EA; Elkind-Hirsch KE; Malinak R
    Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
    Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL; Katz M
    Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
    Winkler UH; Schindler AE; Endrikat J; Düsterberg B
    Contraception; 1996 Feb; 53(2):75-84. PubMed ID: 8838483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
    Fruzzetti F; Ricci C; Fioretti P
    Contraception; 1994 Jun; 49(6):579-92. PubMed ID: 8070263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
    Scott JZ; Kletzky OA; Brenner PF; Mishell DR
    Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and prolactinomas: a case-control study.
    Maheux R; Jenicek M; Cleroux R; Beauregard H; De Muylder X; Gratton NM; Van Campenhout J
    Am J Obstet Gynecol; 1982 May; 143(2):134-8. PubMed ID: 7081323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary prolactinoma and estrogen contraceptives.
    Vaisrub S
    JAMA; 1979 Jul; 242(2):177-8. PubMed ID: 12309457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptive history as a risk indicator in patients with pituitary tumors with hyperprolactinemia: a case comparison study of twenty patients.
    Teperman L; Futterweit W; Zappulla R; Malis LI
    Neurosurgery; 1980 Dec; 7(6):571-3. PubMed ID: 7193811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
    Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
    Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex hormone profiles in oligomenorrheic adolescent girls and the effect of oral contraceptives.
    Siegberg R; Nilsson CG; Stenman UH; Widholm O
    Fertil Steril; 1984 Jun; 41(6):888-93. PubMed ID: 6233177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates.
    Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
    Fertil Steril; 1998 Dec; 70(6):1063-9. PubMed ID: 9848296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.
    Koetsawang S; Charoenvisal C; Banharnsupawat L; Singhakovin S; Kaewsuk O; Punnahitanont S
    Contraception; 1995 Apr; 51(4):225-9. PubMed ID: 7796587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral contraceptives and prolactin-producing hypophyseal tumors].
    Lamberts SW
    Ned Tijdschr Geneeskd; 1980 Jan; 124(4):111-3. PubMed ID: 7374834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.
    Kirkman RJ; Pedersen JH; Fioretti P; Roberts HE
    Contraception; 1994 Jan; 49(1):33-46. PubMed ID: 8137624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation between oral contraceptive use and subsequent development of hyperprolactinemia.
    Badawy SZ; Rebscher F; Kohn L; Wolfe H; Oates RP; Moses A
    Fertil Steril; 1981 Oct; 36(4):464-7. PubMed ID: 7286268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.